Back in July 2015, Cyprotex launched its unique chemPK™ workflow solution for predicting pharmacokinetics directly from chemical structure. This month we released version 2 of chemPK™ with improved functionality such as simulation of repeat dosing regimens and both human PO and IV dosage routes.
In May, we have also been busy presenting our research in publications, at conferences and in video presentations. These include our new review on 3D microtissues published in the Spring Edition of Drug Discovery World, our poster on skin metabolism presented at Great Lakes DMDG and our new video presentation on mitochondrial toxicity.
Continue reading to find out more about these developments.